Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy

Table 5

The relation of parathyroid treatment to the degree of hyperphosphatemia and parathyroid hormone levels.

Parathyroid treatment	Phosphate levels				value
		<6.5	>/= 6.5	Total
	No treatment	5(62.5%)	3(37.5%)	8(100%)	0.58
	Cinacalcet	8(62%)	5(38%)	13(100%)
	Doxercalciferol	1(100%)	0(0.00%)	1(100%)
	Parathyroidectomy	0(0.00%)	1(100%)	1(100%)
	Alendronate	1(100%)	0(0.00%)	1(100%)
Total		15	9	24
Parathyroid treatment	Parathyroid hormone levels
		<600	>/= 600	Total
	No treatment	7(85.5%)	1(12.5%)	8(100%)	0.16
	Cinacalcet	7(53.8%)	6(46.2%)	13(100%)
	Doxercalciferol	0(0.00%)	1(100%)	1(100%)
	Parathyroidectomy	0(0.00%)	1(100%)	1(100%)
	Alendronate	1(100%)	0(0.00%)	1(100%)
Total		15	9	24